New Delhi: Central drug regulator, CDSCO, has initiated risk-based inspection at the manufacturing units of 19 drugs, including cough syrups and antibiotics, across six states following reports of child deaths due to the consumption of contaminated cough syrup in Madhya Pradesh, the health ministry said on Saturday.

The inspections by the Central Drugs Standard Control Organisation (CDSCO) began on October 3 with the aim to identify gaps that may have led to drug quality failures and also suggest process improvement to avoid such incidents in future, it said.

Additionally, a multidisciplinary team comprising experts from the National Institute of Virology, the Indian Council of Medical Research, National Environmental Engineering Research Institute, CDSCO and AIIMS-Nagpur, among others,

See Full Page